Severe Symptomatic Aortic Stenosis Clinical Trial
The purpose of this study is to assess the safety and performance of the 23mm Portico Transcatheter Heart Valve and the TAVI Transapical Delivery System in subjects with severe symptomatic aortic stenosis
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT02210351 -
Evaluation of Association Between Apical Dysfunction and Trans Apical Access for TAVR, in Patients With Severe Aortic Stenosis, Undergoing Trans Apical Trans Catheter Aortic Valve Replacement (TAP-TAVR).
|
N/A | |
Completed |
NCT02956915 -
Evaluation of Length of Stay After TF-TAVI
|
||
Recruiting |
NCT05326126 -
Microvascular Function in Patients Undergoing Transcatheter Aortic Valve Implant (TAVI) for Severe Symptomatic Aortic Stenosis: Association With Myocardial Fibrosis
|
N/A | |
Completed |
NCT04663334 -
Change in Coronary Microcirculation and FFR After TAVI in Patients With Cardiovascular Comorbidities
|
||
Withdrawn |
NCT01927601 -
Assessment of Neurologic Injury Subsequent to Transcatheter Aortic Valve Replacement: A Feasibility Study
|
N/A | |
Completed |
NCT01787084 -
Alternative Access Approaches for Transcatheter Aortic Valve Replace (TAVR) in Inoperable Patients With Aortic Stenosis
|
N/A |